Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.

MLA

Powe, D. G., et al. “Alpha- and Beta-Adrenergic Receptor (AR) Protein Expression Is Associated with Poor Clinical Outcome in Breast Cancer: An Immunohistochemical Study.” Breast Cancer Research and Treatment, vol. 130, no. 2, Nov. 2011, pp. 457–63. EBSCOhost, https://doi.org/10.1007/s10549-011-1371-z.

APA

Powe, D. G., Voss, M. J., Habashy, H. O., Zänker, K. S., Green, A. R., Ellis, I. O., & Entschladen, F. (2011). Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Research and Treatment, 130(2), 457–463. https://doi.org/10.1007/s10549-011-1371-z

Chicago

Powe, D G, M J Voss, H O Habashy, K S Zänker, A R Green, I O Ellis, and F Entschladen. 2011. “Alpha- and Beta-Adrenergic Receptor (AR) Protein Expression Is Associated with Poor Clinical Outcome in Breast Cancer: An Immunohistochemical Study.” Breast Cancer Research and Treatment 130 (2): 457–63. doi:10.1007/s10549-011-1371-z.